Cheng Ying, Jilin Cancer Hospital director and AstraZeneca-funded scientist, dies suddenly
Cheng was a pioneer in clinical trials for tumour diseases, especially small-cell lung carcinoma
A top Chinese oncologist and physician-scientist, Cheng Ying, has died suddenly aged 62, according to multiple sources.
There has been no official statement about the doctor’s death, and the cause of death is not known.
Cheng was director of the Jilin Cancer Hospital and according to their outpatient records, she last appeared at the specialist team clinic she led on the morning of July 2. Subsequently, her appointment schedule was removed from the hospital’s outpatient information sheet, and news about her from the past year has been removed from the hospital’s website.
10:51
New oral treatment for blood cancer offers 97% cure rate, Hong Kong researchers say
The most recent publicly documented appearance by Cheng was on May 10 at the annual meeting of the small-cell carcinoma committee of the Chinese Anti-Cancer Association in Changchun.
Cheng served as chairwoman of the committee at the meeting, where she presented and released a report on research into small-cell carcinoma.
Cheng was a top-tier cancer expert in China. In July 1986, she graduated from Bethune Medical University, now called the School of Medicine, Jilin University.
She then held positions including director, deputy president, president and party secretary at Jilin Cancer Hospital.
In 2009, she received the Chinese medical profession’s highest honour, the Chinese Physician Award, and in 2014, was named Outstanding Hospital President by the Chinese Hospital Association.